entertainment -WSS

entertainment

author：hotspot 2025-10-01 14:19:22 - browse：25614

Hyacinth Empinado/STAT

The body mass index, or BMI, is the formula that’s used most often to diagnose overweight and obesity. But unlike other common diagnoses, there is a certain stigma applied to people with a high body mass index, or BMI, which can affect how they are perceived by peers, providers, and society at large.

Despite the ubiquity of the BMI in medicine, many argue that it is a flawed tool, with a strange history. In recent months, the BMI has become more relevant than ever as the new semaglutide weight loss drugs are poised to change how obesity is understood and treated.

BMI is a simple calculation — a person’s weight in kilograms divided by the square of their height. But how BMI is then translated into a diagnosis is complicated and flawed.

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Watch this video to learn more about the history of the BMI — how it became so entrenched in medicine and, surprisingly, how its introduction may have set back decades of work on how obesity contributes to disease.

A STAT series is examining new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： 'Null' research findings aren't empty of meaning. Let's publish them

explore

WSS

PEPFAR is under serious threat — and so is global health

'Null' research findings aren't empty of meaning. Let's publish them

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Long Covid needs a new name — and a new frame

Physicians aren't 'burning out.' They're suffering from moral injury

The a glaring gap in research on serious mental illness and primary care

knowledge

entertainment

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Tori Bowie and the unacceptable rates of Black maternal death

How housing is health care on Long Island

Moonlake's readout produced a cash windfall. Risks remain

The cancer stories no one wants to hear

Medicare proposal to cover medical devices draws a mixed reaction

FDA proposes changes to key medical devices approval pathway

At least 13 dead in Texas as scorching temps continue

Hospitals consider fixing cancer drug shortages on their own

hotspot

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

How to make the FDA’s new prescription one

CDC recommends RSV monoclonal antibody for infants

Chris Christie meets with Zelenskyy during Ukraine trip

FDA scientists endorse Pfizer/BioNTech Covid

When waiting feels immoral: Empathy in the emergency department

explore

focus

knowledge

knowledge